Nixon Peabody
You are here:  Home  >  Biotech  >  Current Article

Cure Pharmaceuticals makes licensing deal with Vanguard Scientific

By   /   Thursday, February 13th, 2020  /   No Comments

    Print       Email
Cure Pharmaceuticals announced a licensing deal with Oregon-based Vanguard Scientific for its cannabis extraction technology. Oxnard drug delivery and cannabis research firm Cure develops thin dissolvable strips for oral drug delivery. The agreement allows Vanguard, which provides equipment for botanical extraction, to use its patents on isolating cannabinoids using various solvents like CO2 and developing…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

Leave a Reply

Your email address will not be published. Required fields are marked *

You might also like...

LTC Properties beats fourth-quarter earnings estimates

Read More →